Amare M, Abdou N L, Robinson M G, Abdou N I
Am J Hematol. 1978;5(1):25-32. doi: 10.1002/ajh.2830050104.
In five patients with idiopathic aplastic anemia, the colony-forming unit (CFU-c) assay was used to quantitate stem cells and test the possible presence of suppressor cells inhibiting bone marrow differentiation. All five marrows failed to form CFU-c. In one out of the five cases tested, coculture of the patient's marrow with normal marrow suppressed the latter to form CFU-c. Removal of T-cells from the patient's bone marrow freed the aplastic marrow to produce more colonies and, in the coculture study, abrogated its inhibitory activity on the normal bone marrow. Treatment of the patient with horse antihuman thymocyte globulin (ATG), improved the peripheral blood count and myelopoiesis. Furthermore, the aplastic marrow increased its colony forming capacity from less than 1% pre-ATG to 46% post-ATG of the normal control, and its inhibitory activity on the normal marrow was ablated. In selected cases of aplastic anemia, with evidence of T-suppressor cell hyperactivity, treatment with ATG may offer an alternative approach to bone-marrow transplantation.
在5例特发性再生障碍性贫血患者中,采用集落形成单位(CFU-c)测定法对干细胞进行定量,并检测抑制骨髓分化的抑制细胞是否可能存在。所有5例患者的骨髓均未能形成CFU-c。在5例检测病例中的1例中,患者骨髓与正常骨髓共培养抑制了后者形成CFU-c。从患者骨髓中去除T细胞后,再生障碍性骨髓能够产生更多集落,并且在共培养研究中,消除了其对正常骨髓的抑制活性。用马抗人胸腺细胞球蛋白(ATG)治疗该患者后,外周血细胞计数和骨髓生成得到改善。此外,再生障碍性骨髓的集落形成能力从ATG治疗前低于正常对照的1%增加到ATG治疗后的46%,并且其对正常骨髓的抑制活性被消除。在某些有T抑制细胞功能亢进证据的再生障碍性贫血病例中,用ATG治疗可能为骨髓移植提供一种替代方法。